Debt to EBITDA ratio Analysis of Evaxion Biotech AS - Deep Dive
Debt to EBITDA of EVAX
Dec-23-0.377Very Poor Debt to EBITDA | Dec-22-0.364Very Poor Debt to EBITDA | Growth-3.54% |
Debt to EBITDA Analysis of Evaxion Biotech AS
Debt to EBITDA Ratio of EVAX has fallen by -3.54 % Compared to previous Financial Year. |
Debt to EBITDA Ratio with value of -0.0012 was highest in Year Dec-20 in last Five Years. |
Debt to EBITDA Ratio of EVAX trending down for at least three Years. |
Latest Debt to EBITDA Ratio with value of -0.377 is lower than Average Debt to EBITDA of -0.161 in last five years. |
Other Debt to EBITDA Related Info of EVAX that may interest you.
Evaxion Biotech AS Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
EVAX | 3.72 | 3.83 | 2.87 % | Biotechnology |
Defination of Debt to EBITDA
The Debt to EBITDA Ratio is a solvency metric that measures the company's ability to meet its debt obligations by earnings before covering its interest, taxes, depreciation, and amortization. more ..Debt to EBITDA Related Ratios
CashFlowFromOperationToDebt | DebtToCapital | EVToEBITDA |
Tsr Stability Index
Poor Stability Stock |
FY - Historical Debt to EBITDA of Evaxion Biotech AS
Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
---|---|---|---|---|---|---|---|
Debt to EBITDA | -0.377 | -0.364 | -0.061 | -0.0012 | -0.0034 | -1.57 | 0 |
Change | -3.54 % | -493.86 % | -4939.54 % | 63.79 % | 99.79 % |
FY Chart of Debt to EBITDA of Evaxion Biotech AS
Note : All Data Generated at the End of Trading Hours (EOD Data)